GLP-1 Receptor Agonist Discontinuation Among Patients With Obesity and/or Type 2 Diabetes

被引：59

作者：

Do, Duy ^{[1
]}

Lee, Tiffany ^{[1
]}

Peasah, Samuel K. ^{[2
]}

Good, Chester B. ^{[2
]}

Inneh, Angela ^{[1
]}

Patel, Urvashi ^{[1
]}

机构：

[1] Evernorth Res Inst, One Express Way, St Louis, MO 63121 USA

[2] UPMC Hlth Plan, Ctr Value Based Pharm Initiat, Pittsburgh, PA USA

来源：

JAMA NETWORK OPEN | 2024年 / 7卷 / 05期

关键词：

LIRAGLUTIDE;

D O I：

10.1001/jamanetworkopen.2024.13172

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This cohort study examines the prevalence of and factors associated with glucagon-like peptide 1 agonist discontinuation among new users.

引用

页数：4

共 3 条

[1] Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined [J].

Lundgren, Julie R. ;

Janus, Charlotte ;

Jensen, Simon B. K. ;

Juhl, Christian R. ;

Olsen, Lisa M. ;

Christensen, Rasmus M. ;

Svane, Maria S. ;

Bandholm, Thomas ;

Bojsen-Moller, Kirstine N. ;

Blond, Martin B. ;

Jensen, Jens-Erik B. ;

Stallknecht, Bente M. ;

Holst, Jens J. ;

Madsbad, Sten ;

Torekov, Signe S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (18) :1719-1730

[2]

Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI [10.1056/NEJMoa1603827, 10.1056/NEJMc1615712]

[3] Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK [J].

Weiss, Tracey ;

Yang, Lingfeng ;

Carr, Richard D. ;

Pal, Sampriti ;

Sawhney, Baanie ;

Boggs, Robert ;

Rajpathak, Swapnil ;

Iglay, Kristy .

BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (01)

← 1 →